AAAAAA
Results:
1-23
|
Results: 23
Authors:
RICKE J
WOLF M
ZIELINSKI C
HOSTEN N
LIEBIG T
AMTHAUER H
HANNINEN EL
SCHUMACHER T
STROSZCZYNSKI C
BERGH B
EMMEL D
SCHAUER W
Citation: J. Ricke et al., COMPARATIVE FINDINGS OF DIGITAL CHEST IMA GES AND DIGITAL IMAGES A PHANTOM REVIEWED WITH FILM, A RADIOLOGICAL WORK STATION AND A PC, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 168(3), 1998, pp. 264-269
Authors:
RICKE J
MAASS P
HANNINEN EL
LIEBIG T
AMTHAUER H
STROSZCZYNSKI C
SCHAUER W
BOSKAMP T
WOLF M
Citation: J. Ricke et al., WAVELET VERSUS JPEG (JOINT PHOTOGRAPHIC EXPERT GROUP) AND FRACTAL COMPRESSION - IMPACT ON THE DETECTION OF LOW-CONTRAST DETAILS IN COMPUTEDRADIOGRAPHS, Investigative radiology, 33(8), 1998, pp. 456-463
Authors:
HANNINEN EL
VOGL TJ
BECHSTEIN WO
GUCKELBERGER O
NEUHAUS P
LOBECK H
FELIX R
Citation: El. Hanninen et al., BIPHASIC SPIRAL COMPUTED-TOMOGRAPHY FOR DETECTION OF HEPATOCELLULAR-CARCINOMA BEFORE RESECTION OR ORTHOTOPIC LIVER-TRANSPLANTATION, Investigative radiology, 33(4), 1998, pp. 216-221
Authors:
VOGL TJ
HANNINEN EL
BECHSTEIN WO
NEUHAUS P
SCHUMACHER G
FELIX R
Citation: Tj. Vogl et al., BIPHASIC SPIRAL COMPUTED-TOMOGRAPHY VERSUS DIGITAL SUBTRACTION ANGIOGRAPHY FOR EVALUATION OF ARTERIAL THROMBOSIS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION, Investigative radiology, 33(3), 1998, pp. 136-140
Authors:
DUENSING S
VANDENBERGDERUITER E
STORKEL S
KIRCHNER H
HANNINEN EL
BUER J
POLIWODA H
ATZPODIEN J
Citation: S. Duensing et al., CYTOGENETIC STUDIES IN RENAL-CELL CARCINOMA PATIENTS RECEIVING LOW-DOSE RECOMBINANT INTERLEUKIN-2-BASED IMMUNOTHERAPY, Tumor biology, 17(1), 1996, pp. 27-33
Authors:
HANNINEN EL
KIRCHNER H
ATZPODIEN J
Citation: El. Hanninen et al., INTERLEUKIN-2 BASED HOME THERAPY OF METASTATIC RENAL-CELL CARCINOMA -RISKS AND BENEFITS IN 215 CONSECUTIVE SINGLE INSTITUTION PATIENTS, The Journal of urology, 155(1), 1996, pp. 19-25
Authors:
BUER J
HILSE R
DALLMANN I
GROSSE J
KIRCHNER H
ZORN U
HANNINEN EL
FRANZKE A
DUENSING S
POLIWODA H
ATZPODIEN J
Citation: J. Buer et al., LYMPHOCYTE-CONDITIONED MEDIUM IN COMBINATION WITH INTERLEUKIN-2 EFFECTIVELY INDUCES ANTITUMOR AUTOIMMUNITY BY ADOPTIVE TRANSFER OF SHORT ACTIVATED KILLER (SHAK) CELLS, Cytokines and molecular therapy, 1(1), 1995, pp. 39-46
Authors:
HANNINEN EL
POLIWODA H
ATZPODIEN J
Citation: El. Hanninen et al., INTERFERON-ALPHA 5-FLUOROURACIL - A NOVEL OUTPATIENT CHEMO IMMUNOTHERAPY FOR PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA/, Cancer biotherapy, 10(1), 1995, pp. 21-24
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
FRANZKE A
KORFER AK
VOLKENANDT M
DUENSING S
SCHOMBURG A
CHAITCHIK S
POLIWODA H
Citation: J. Atzpodien et al., CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT-MELANOMA - SEQUENTIAL ADMINISTRATION OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA AFTER INTRAVENOUS DACARBAZINE AND CARBOPLATIN OR INTRAVENOUS DACARBAZINE, CISPLATIN, CARMUSTINE AND TAMOXIFEN, European journal of cancer, 31A(6), 1995, pp. 876-881
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
BODENSTEIN H
PFREUNDSCHUH M
REBMANN U
METZNER B
ILLIGER HJ
JAKSE G
NIESEL T
SCHOLZ HJ
WILHELM S
PIELMEIER T
ZAKRZEWSKI G
BLUM G
BEIER J
MULLER GW
DUENSING S
ANTON P
ALLHOFF E
JONAS U
POLIWODA H
Citation: J. Atzpodien et al., MULTIINSTITUTIONAL HOME-THERAPY TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-2 AND INTERFERON ALFA-2 IN PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA, Journal of clinical oncology, 13(2), 1995, pp. 497-501
Authors:
ATZPODIEN J
KIRCHNER H
DUENSING S
HANNINEN EL
FRANZKE A
BUER J
PROBST M
ANTON P
POLIWODA H
Citation: J. Atzpodien et al., BIOCHEMOTHERAPY OF ADVANCED METASTATIC RENAL-CELL CARCINOMA - RESULTSOF THE COMBINATION OF INTERLEUKIN-2, ALPHA-INTERFERON, 5-FLUOROURACIL, VINBLASTINE, AND 13-CIS-RETINOIC ACID, World journal of urology, 13(3), 1995, pp. 174-177
Authors:
MEFFERT M
SCHOMBURG A
HANNINEN EL
MENZEL T
VOCKE S
DALLMANN I
GROSSE J
DUENSING S
BUER J
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TUMOR-NECROSIS-FACTOR-ALPHA AS INDICATOR OF BIOLOGIC AND CLINICAL-RESPONSE TO LOW-DOSE SC RECOMBINANT INTERLEUKIN-2, Anticancer research, 15(1), 1995, pp. 127-132
Authors:
MEFFERT M
HANNINEN EL
MENZEL T
SCHOMBURG A
DUENSING S
DALLMANN I
GROSSE J
VOCKE S
BUER J
DECKERT M
HILSE R
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Meffert et al., IN-VIVO TIME AND DOSE-DEPENDENCY OF INTERLEUKIN-6 SECRETION IN RESPONSE TO LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2, Cancer biotherapy, 9(4), 1994, pp. 307-316
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
KNUVERHOPF J
POLIWODA H
Citation: J. Atzpodien et al., HUMAN-ANTIBODIES TO RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH HYPERNEPHROMA, Journal of interferon research, 14(4), 1994, pp. 177-178
Authors:
DUENSING S
DALLMANN I
GROSSE J
BUER J
HANNINEN EL
DECKERT M
STORKEL S
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: S. Duensing et al., IMMUNOCYTOCHEMICAL DETECTION OF P-GLYCOPROTEIN - INITIAL EXPRESSION CORRELATES WITH SURVIVAL IN RENAL-CELL CARCINOMA PATIENTS, Oncology, 51(4), 1994, pp. 309-313
Authors:
ATZPODIEN J
KIRCHNER H
HANNINEN EL
MENZEL T
DECKERT M
FRANZKE A
SCHOMBURG A
POLIWODA H
Citation: J. Atzpodien et al., TREATMENT OF METASTATIC COLORECTAL-CANCER PATIENTS WITH 5-FLUOROURACIL IN COMBINATION WITH RECOMBINANT SUBCUTANEOUS HUMAN INTERLEUKIN-2 ANDALPHA-INTERFERON, Oncology, 51(3), 1994, pp. 273-275
Authors:
DUENSING S
GUNER D
GROSSE J
HANNINEN EL
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: S. Duensing et al., INCREASED EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR (BFGF) AND FGFRECEPTOR-1 (FGFR1) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 84(10), 1994, pp. 10000653-10000653
Authors:
HANNINEN EL
FENNER M
KIRCHNER H
DECKERT M
DUENSING S
MENZEL T
POLIWODA H
ATZPODIEN J
Citation: El. Hanninen et al., LIMITED EFFICACY OF INTERFERON-ALPHA AND VINBLASTINE AS 2ND LINE BIOCHEMOTHERAPY REGIMEN IN PATIENTS WITH PROGRESSIVE METASTATIC RENAL-CELLCARCINOMA, Cancer biotherapy, 8(4), 1993, pp. 301-306
Authors:
ATZPODIEN J
KIRCHNER H
HANNINEN EL
DECKERT M
FENNER M
POLIWODA H
Citation: J. Atzpodien et al., INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA AND 5-FLUOROURACILFOR METASTATIC RENAL-CELL CANCER, European journal of cancer, 29A, 1993, pp. 6-8
Authors:
HANNINEN EL
KNUVERHOPF J
ATZPODIEN J
Citation: El. Hanninen et al., IMMUNOGENICITY OF RECOMBINANT HUMAN INTERLEUKIN-2 - BIOLOGICAL FEATURES AND CLINICAL RELEVANCE, Biotherapy, 6(4), 1993, pp. 251-261
Authors:
ATZPODIEN J
KIRCHNER H
HANNINEN EL
KORFER A
FENNER M
MENZEL T
DECKERT M
FRANZKE A
JONAS U
POLIWODA H
Citation: J. Atzpodien et al., EUROPEAN STUDIES OF INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA, Seminars in oncology, 20(6), 1993, pp. 22-26
Authors:
ATZPODIEN J
MEFFERT M
HANNINEN EL
DECKERT M
FRANZKE A
KIRCHNER H
POLIWODA H
Citation: J. Atzpodien et al., INTERLEUKIN-2 INDUCED TUMOR-NECROSIS-FACTOR-ALPHA AS PREDICTOR OF SURVIVAL IN ADVANCED TUMOR PATIENTS, Blood, 82(10), 1993, pp. 10000515-10000515
Authors:
SCHNEEKLOTH C
KORFER A
HADAM M
HANNINEN EL
MENZEL T
SCHOMBURG A
DALLMANN I
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: C. Schneekloth et al., LOW-DOSE INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA EFFECTIVELY MODULATES BIOLOGICAL RESPONSE INVIVO, Acta haematologica, 89(1), 1993, pp. 13-21
Risultati:
1-23
|